A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer ...

Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

Eight people who had surgery for pancreatic cancer and then received a vaccine built from their own tumor DNA have now gone ...

A personalized mRNA vaccine may change melanoma treatment, with 70% of patients cancer-free after 5 years. Discover how this ...

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer ...

A small but striking study is giving cancer researchers another reason to closely watch a new kind of treatment. An experimental personalized mRNA vaccine showed lasting results in some patients with ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...